Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm Rowland

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
The use of isotopes in the determination of absolute bioavailability of drugs in humansGraham Lappin, Malcolm Rowland, R Colin Garner
Journal of Pharmacokinetics and Pharmacodynamics|December 22, 2005
Reducing whole body physiologically based pharmacokinetic models using global sensitivity analysis: diazepam case studyIvelina Gueorguieva, Ivan A Nestorov, Malcolm Rowland
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 6, 2021
In Defense of Current Concepts and Applications of Clearance in Drug Development and TherapeuticsMalcolm Rowland, Michael S Roberts, K Sandy Pang
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 29, 2005
The pharmacokinetics of perindoprilat in normal volunteers and patients: influence of age and disease stateEva Parker, Leon Aarons, Malcolm Rowland, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 12, 2005
Getting the Dose Right: report from the Tenth European Federation of Pharmaceutical Sciences (EUFEPS) conference on optimizing drug developmentDonald R Stanski, Malcolm Rowland, Lewis B Sheiner
Journal of Pharmacokinetics and Pharmacodynamics|November 3, 2004
Fuzzy simulation of pharmacokinetic models: case study of whole body physiologically based model of diazepamIvelina I Gueorguieva, Ivan A Nestorov, Malcolm Rowland
Expert Opinion on Drug Metabolism & Toxicology|July 21, 2009
Human clearance prediction: shifting the paradigmThierry Lavé, Kathryn Chapman, Paul Goldsmith, et al.
Therapeutic Drug Monitoring|January 28, 2003
A Bayesian method based on clotting factor activity for the prediction of maintenance warfarin dosage regimensMaria Pitsiu, Eva M Parker, Leon Aarons, et al.
Pharmaceutical Research|September 24, 2005
Uncertainty analysis in pharmacokinetics and pharmacodynamics: application to naratriptanIvelina Gueorguieva, Ivan A Nestorov, Leon Aarons, et al.
Journal of Pharmaceutical Sciences|June 29, 2011
Toward an integrated human clearance prediction strategy that minimizes animal useKevin Beaumont, Iain Gardner, Kathryn Chapman, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
The use of isotopes in the determination of absolute bioavailability of drugs in humansGraham Lappin, Malcolm Rowland, R Colin Garner
Journal of Pharmacokinetics and Pharmacodynamics|December 22, 2005
Reducing whole body physiologically based pharmacokinetic models using global sensitivity analysis: diazepam case studyIvelina Gueorguieva, Ivan A Nestorov, Malcolm Rowland
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 6, 2021
In Defense of Current Concepts and Applications of Clearance in Drug Development and TherapeuticsMalcolm Rowland, Michael S Roberts, K Sandy Pang
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 29, 2005
The pharmacokinetics of perindoprilat in normal volunteers and patients: influence of age and disease stateEva Parker, Leon Aarons, Malcolm Rowland, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 12, 2005
Getting the Dose Right: report from the Tenth European Federation of Pharmaceutical Sciences (EUFEPS) conference on optimizing drug developmentDonald R Stanski, Malcolm Rowland, Lewis B Sheiner
Journal of Pharmacokinetics and Pharmacodynamics|November 3, 2004
Fuzzy simulation of pharmacokinetic models: case study of whole body physiologically based model of diazepamIvelina I Gueorguieva, Ivan A Nestorov, Malcolm Rowland
Expert Opinion on Drug Metabolism & Toxicology|July 21, 2009
Human clearance prediction: shifting the paradigmThierry Lavé, Kathryn Chapman, Paul Goldsmith, et al.
Therapeutic Drug Monitoring|January 28, 2003
A Bayesian method based on clotting factor activity for the prediction of maintenance warfarin dosage regimensMaria Pitsiu, Eva M Parker, Leon Aarons, et al.
Pharmaceutical Research|September 24, 2005
Uncertainty analysis in pharmacokinetics and pharmacodynamics: application to naratriptanIvelina Gueorguieva, Ivan A Nestorov, Leon Aarons, et al.
Journal of Pharmaceutical Sciences|June 29, 2011
Toward an integrated human clearance prediction strategy that minimizes animal useKevin Beaumont, Iain Gardner, Kathryn Chapman, et al.
Pageof 6